X-rays radiomics-based machine learning classification of atypical cartilaginous tumour and high-grade chondrosarcoma of long bones.


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 05 11 2023
revised: 03 02 2024
accepted: 04 02 2024
medline: 18 3 2024
pubmed: 21 2 2024
entrez: 20 2 2024
Statut: ppublish

Résumé

Atypical cartilaginous tumour (ACT) and high-grade chondrosarcoma (CS) of long bones are respectively managed with active surveillance or curettage and wide resection. Our aim was to determine diagnostic performance of X-rays radiomics-based machine learning for classification of ACT and high-grade CS of long bones. This retrospective, IRB-approved study included 150 patients with surgically treated and histology-proven lesions at two tertiary bone sarcoma centres. At centre 1, the dataset was split into training (n = 71 ACT, n = 24 high-grade CS) and internal test (n = 19 ACT, n = 6 high-grade CS) cohorts, respectively, based on the date of surgery. At centre 2, the dataset constituted the external test cohort (n = 12 ACT, n = 18 high-grade CS). Manual segmentation was performed on frontal view X-rays, using MRI or CT for preliminary identification of lesion margins. After image pre-processing, radiomic features were extracted. Dimensionality reduction included stability, coefficient of variation, and mutual information analyses. In the training cohort, after class balancing, a machine learning classifier (Support Vector Machine) was automatically tuned using nested 10-fold cross-validation. Then, it was tested on both the test cohorts and compared to two musculoskeletal radiologists' performance using McNemar's test. Five radiomic features (3 morphology, 2 texture) passed dimensionality reduction. After tuning on the training cohort (AUC = 0.75), the classifier had 80%, 83%, 79% and 80%, 89%, 67% accuracy, sensitivity, and specificity in the internal (temporally independent) and external (geographically independent) test cohorts, respectively, with no difference compared to the radiologists (p ≥ 0.617). X-rays radiomics-based machine learning accurately differentiates between ACT and high-grade CS of long bones. AIRC Investigator Grant.

Sections du résumé

BACKGROUND BACKGROUND
Atypical cartilaginous tumour (ACT) and high-grade chondrosarcoma (CS) of long bones are respectively managed with active surveillance or curettage and wide resection. Our aim was to determine diagnostic performance of X-rays radiomics-based machine learning for classification of ACT and high-grade CS of long bones.
METHODS METHODS
This retrospective, IRB-approved study included 150 patients with surgically treated and histology-proven lesions at two tertiary bone sarcoma centres. At centre 1, the dataset was split into training (n = 71 ACT, n = 24 high-grade CS) and internal test (n = 19 ACT, n = 6 high-grade CS) cohorts, respectively, based on the date of surgery. At centre 2, the dataset constituted the external test cohort (n = 12 ACT, n = 18 high-grade CS). Manual segmentation was performed on frontal view X-rays, using MRI or CT for preliminary identification of lesion margins. After image pre-processing, radiomic features were extracted. Dimensionality reduction included stability, coefficient of variation, and mutual information analyses. In the training cohort, after class balancing, a machine learning classifier (Support Vector Machine) was automatically tuned using nested 10-fold cross-validation. Then, it was tested on both the test cohorts and compared to two musculoskeletal radiologists' performance using McNemar's test.
FINDINGS RESULTS
Five radiomic features (3 morphology, 2 texture) passed dimensionality reduction. After tuning on the training cohort (AUC = 0.75), the classifier had 80%, 83%, 79% and 80%, 89%, 67% accuracy, sensitivity, and specificity in the internal (temporally independent) and external (geographically independent) test cohorts, respectively, with no difference compared to the radiologists (p ≥ 0.617).
INTERPRETATION CONCLUSIONS
X-rays radiomics-based machine learning accurately differentiates between ACT and high-grade CS of long bones.
FUNDING BACKGROUND
AIRC Investigator Grant.

Identifiants

pubmed: 38377797
pii: S2352-3964(24)00053-7
doi: 10.1016/j.ebiom.2024.105018
pmc: PMC10884340
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105018

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests Matteo Interlenghi: CTO and employee of DeepTrace Technologies. DeepTrace Technologies is a spin-off of Scuola Universitaria Superiore IUSS, Pavia, Italy; shareholder in DeepTrace Technologies. Christian Salvatore: CEO of DeepTrace Technologies. DeepTrace Technologies is a spin-off of Scuola Universitaria Superiore IUSS, Pavia, Italy; shareholder in DeepTrace Technologies. Isabella Castiglioni: Shareholder in DeepTrace Technologies. All other authors declare that they have no conflicts of interest to disclose.

Auteurs

Salvatore Gitto (S)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.

Alessio Annovazzi (A)

Nuclear Medicine Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Kitija Nulle (K)

Radiology Department, Riga East Clinical University Hospital, Riga, Latvia.

Matteo Interlenghi (M)

DeepTrace Technologies s.r.l., Milan, Italy.

Christian Salvatore (C)

DeepTrace Technologies s.r.l., Milan, Italy; Department of Science, Technology and Society, University School for Advanced Studies IUSS Pavia, Pavia, Italy.

Vincenzo Anelli (V)

Radiology and Diagnostic Imaging Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Jacopo Baldi (J)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Carmelo Messina (C)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.

Domenico Albano (D)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy; Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Milan, Italy.

Filippo Di Luca (F)

Scuola di Specializzazione in Radiodiagnostica, Università degli Studi di Milano, Milan, Italy.

Elisabetta Armiraglio (E)

UOC Anatomia Patologica, ASST Gaetano Pini - CTO, Milan, Italy.

Antonina Parafioriti (A)

UOC Anatomia Patologica, ASST Gaetano Pini - CTO, Milan, Italy.

Alessandro Luzzati (A)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Roberto Biagini (R)

Oncological Orthopaedics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Isabella Castiglioni (I)

Department of Physics "G. Occhialini", Università degli Studi di Milano-Bicocca, Milan, Italy.

Luca Maria Sconfienza (LM)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy. Electronic address: io@lucasconfienza.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH